go back

Tocilizumab Infusion for COVID-19, First Dose

Maryland rates for HCPCS M0249

Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with COVID-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, first dose

Rates data updated July 2026.

Facilitymedian $447 · 10th–90th $447$4470%50%100%$447Professionalmedian $447 · 10th–90th $447$6920%50%90th$447$500.0$1.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$446.68
Median
$446.68
Typical High
$446.68
Aetna
Setting
Professional
Modifier
Global
Typical Low
$446.68
Median
$446.68
Typical High
$446.68
CareFirst
Setting
Professional
Modifier
Global
Typical Low
$501.19
Median
$501.19
Typical High
$501.19
Cigna
Setting
Professional
Modifier
Global
Typical Low
$398.11
Median
$398.11
Typical High
$398.11
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$478.63
Median
$549.54
Typical High
$691.83
United
Setting
Professional
Modifier
Global
Typical Low
$416.87
Median
$616.60
Typical High
$1,202.26
Wellpoint
Setting
Professional
Modifier
Global
Typical Low
$446.68
Median
$446.68
Typical High
$446.68